Atalanta Sosnoff Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-402,714
| Closed | -$25.3M | – | 114 |
|
|
2026
Q1 | $25.3M | Sell |
402,714
-249,281
| -38% | -$19.9M | 0.54% | 45 |
|
|
2025
Q4 | $62.2M | Sell |
651,995
-43,573
| -6% | -$4.27M | 1.21% | 28 |
|
|
2025
Q3 | $67.9M | Sell |
695,568
-19,199
| -3% | -$1.99M | 1.3% | 25 |
|
|
2025
Q2 | $76.8M | Sell |
714,767
-27,889
| -4% | -$2.82M | 1.56% | 22 |
|
|
2025
Q1 | $74.9M | Buy |
742,656
+1,850
| +0.2% | +$186K | 1.79% | 19 |
|
|
2024
Q4 | $66.2M | Sell |
740,806
-23,038
| -3% | -$2.03M | 1.44% | 25 |
|
|
2024
Q3 | $64M | Sell |
763,844
-3,476
| -0.5% | -$274K | 1.37% | 26 |
|
|
2024
Q2 | $59.1M | Buy |
767,320
+11,606
| +2% | +$850K | 1.33% | 25 |
|
|
2024
Q1 | $51.8M | Buy |
755,714
+24,543
| +3% | +$1.58M | 1.2% | 30 |
|
|
2023
Q4 | $42.3M | Sell |
731,171
-11,434
| -2% | -$610K | 1.09% | 39 |
|
|
2023
Q3 | $39.2M | Sell |
742,605
-21,108
| -3% | -$1.11M | 1.16% | 34 |
|
|
2023
Q2 | $41.3M | Sell |
763,713
-324,351
| -30% | -$16.9M | 1.12% | 34 |
|
|
2023
Q1 | $54.4M | Sell |
1,088,064
-10,834
| -1% | -$511K | 1.58% | 18 |
|
|
2022
Q4 | $50.8M | Sell |
1,098,898
-23,678
| -2% | -$1.03M | 1.57% | 22 |
|
|
2022
Q3 | $43.5M | Sell |
1,122,576
-4,337
| -0.4% | -$174K | 1.37% | 27 |
|
|
2022
Q2 | $42M | Sell |
1,126,913
-27,767
| -2% | -$1.13M | 1.27% | 29 |
|
|
2022
Q1 | $51.1M | Buy |
1,154,680
+38,621
| +3% | +$1.67M | 1.2% | 31 |
|
|
2021
Q4 | $47.4M | Sell |
1,116,059
-298,613
| -21% | -$12.5M | 1.02% | 34 |
|
|
2021
Q3 | $61.4M | Buy |
1,414,672
+868,038
| +159% | +$38.4M | 1.44% | 28 |
|
|
2021
Q2 | $23.4M | Buy |
546,634
+29,479
| +6% | +$1.24M | 0.54% | 43 |
|
|
2021
Q1 | $20M | Sell |
517,155
-1,705
| -0.3% | -$64.5K | 0.49% | 51 |
|
|
2020
Q4 | $18.7M | Sell |
518,860
-873,677
| -63% | -$31.5M | 0.48% | 55 |
|
|
2020
Q3 | $53.2M | Sell |
1,392,537
-39,683
| -3% | -$1.53M | 1.51% | 24 |
|
|
2020
Q2 | $50.3M | Sell |
1,432,220
-463,369
| -24% | -$16.7M | 1.52% | 23 |
|
|
2020
Q1 | $61.9M | Buy |
1,895,589
+415,093
| +28% | +$16.2M | 2.2% | 11 |
|
|
2019
Q4 | $66.9M | Sell |
1,480,496
-18,725
| -1% | -$784K | 1.99% | 13 |
|
|
2019
Q3 | $61M | Buy |
1,499,221
+306,933
| +26% | +$13M | 1.98% | 19 |
|
|
2019
Q2 | $51.2M | Sell |
1,192,288
-32,961
| -3% | -$1.27M | 1.61% | 25 |
|
|
2019
Q1 | $47M | Buy |
1,225,249
+9,319
| +0.8% | +$356K | 1.47% | 31 |
|
|
2018
Q4 | $43M | Sell |
1,215,930
-9,667
| -0.8% | -$351K | 1.56% | 29 |
|
|
2018
Q3 | $47.2M | Sell |
1,225,597
-21,455
| -2% | -$749K | 1.41% | 33 |
|
|
2018
Q2 | $40.8M | Buy |
1,247,052
+32,009
| +3% | +$965K | 1.34% | 33 |
|
|
2018
Q1 | $33.2M | Buy |
1,215,043
+22,857
| +2% | +$621K | 1.11% | 36 |
|
|
2017
Q4 | $29.6M | Sell |
1,192,186
-26,292
| -2% | -$725K | 0.96% | 45 |
|
|
2017
Q3 | $35.5M | Sell |
1,218,478
-21,031
| -2% | -$581K | 1.23% | 34 |
|
|
2017
Q2 | $34.4M | Sell |
1,239,509
-44,172
| -3% | -$1.17M | 1.21% | 37 |
|
|
2017
Q1 | $31.9M | Sell |
1,283,681
-67,344
| -5% | -$1.64M | 1.12% | 41 |
|
|
2016
Q4 | $29.2M | Sell |
1,351,025
-114,851
| -8% | -$2.51M | 1.04% | 39 |
|
|
2016
Q3 | $34.9M | Sell |
1,465,876
-69,773
| -5% | -$1.66M | 1.21% | 35 |
|
|
2016
Q2 | $35.9M | Sell |
1,535,649
-1,738,640
| -53% | -$37.6M | 1.2% | 33 |
|
|
2016
Q1 | $61.6M | Buy |
3,274,289
+271,413
| +9% | +$4.77M | 1.94% | 15 |
|
|
2015
Q4 | $55.4M | Sell |
3,002,876
-78,606
| -3% | -$1.41M | 1.65% | 27 |
|
|
2015
Q3 | $50.6M | Sell |
3,081,482
-436,890
| -12% | -$7.47M | 1.61% | 27 |
|
|
2015
Q2 | $62.3M | Buy |
3,518,372
+698,827
| +25% | +$12.5M | 1.71% | 22 |
|
|
2015
Q1 | $50M | Buy |
+2,819,545
| New | +$44.6M | 1.33% | 35 |
|
Other funds holding BSX
Atalanta Sosnoff Capital's BSX Position: Q2 2026 in Review
Atalanta Sosnoff Capital sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 402,714 shares — an estimated $25.3M sold.
Atalanta Sosnoff Capital first reported a position in BSX in Q1 2015 and held it in 45 quarters. The position peaked at $76.8M in Q2 2025. 1,465 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Atalanta Sosnoff Capital reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Atalanta Sosnoff Capital sold 402,714 Boston Scientific shares in Q2 2026, an estimated $25.3M.
- Atalanta Sosnoff Capital first reported a position in Boston Scientific in Q1 2015 and held it in 45 quarters.
- Atalanta Sosnoff Capital's Boston Scientific position peaked at $76.8M in Q2 2025.
- 1,465 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.